Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |